Last updated 16 July 2021
The last batch of global asparaginase Erwinia chrysanthemi/crisantaspase (Erwinia L-asparaginase) distribution by Jazz has been released, and this was the last batch made available by Porton Biopharma Limited (PBL) to Jazz. Jazz’s right to distribute the product ceased after this batch. All supply beyond this batch is the responsibility of PBL and Clinigen.
Any questions related to future batch availability should be directed to PBL’s new partner, Clinigen.
Jazz thanks the healthcare providers, health authorities and patient community for their engagement and partnership over the last several years and the company remains committed to this patient population.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.